Immunogenicity of a novel, bivalent, plant-based oral vaccine against hepatitis B and human immunodeficiency viruses
Immunogenicity of a novel, bivalent, plant-based oral vaccine against hepatitis B and human immunodeficiency viruses
复制标题
针对乙型肝炎和人类免疫缺陷病毒的新型二价植物口服疫苗的免疫原性
DOI:
10.1007/s10529-006-9028-4
复制
发表时间:
2006
影响因子:
2.7
通讯作者:
R. Hammond
中科院分区:
文献类型:
--
作者:
S. Shchelkunov;R. K. Salyaev;S. G. Pozdnyakov;N. Rekoslavskaya;A. E. Nesterov;T. S. Ryzhova;V. M. Sumtsova;N. V. Pakova;U. O. Mishutina;T. V. Kopytina;R. Hammond
A synthetic chimeric gene, TBI-HBS, encoding the immunogenic ENV and GAG epitopes of human immunodeficiency virus (HIV-1) and the surface protein antigen (HBsAg) of hepatitis B virus (HBV), was expressed in tomato plants. Tomato fruits containing the TBI-HBS antigen were fed to experimental mice and, on days 14 and 28 post-feeding, high levels of HIV- and HBV-specific antibodies were present in the serum and feces of the test animals. Intraperitoneal injection of a DNA vaccine directing synthesis of the same TBI-HBsAg antigen boosted the antibody response to HIV in the blood serum; however, it had no effect on the high level of antibodies produced to HBV.
DOI:
10.1073/pnas.0409899102
发表时间:
2005-03-01
影响因子:
11.1
作者:
Thanavala, Y;Mahoney, M;Mason, HS
通讯作者:
Mason, HS